相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Botulinum toxin type A and cervical dystonia A seven-year follow-up
Carlos Henrique F. Camargo et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2011)
EFNS guidelines on diagnosis and treatment of primary dystonias
A. Albanese et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study
Pedro J. Garcia Ruiz et al.
JOURNAL OF NEUROLOGY (2011)
Long-Term Efficacy of Botulinum A Toxin for Blepharospasm and Hemifacial Spasm
Harmeet S. Gill et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)
Craniocervical dystonia: clinical and pathophysiological features
C. Colosimo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series
A. Blitzer
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes
S. Cillino et al.
EYE (2010)
Psychiatric Disorders in Adult-Onset Focal Dystonia: A Case-Control Study
Giovanni Fabbrini et al.
MOVEMENT DISORDERS (2010)
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia
Daniel Truong et al.
PARKINSONISM & RELATED DISORDERS (2010)
Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients
Fernanda Martins Maia et al.
PARKINSONISM & RELATED DISORDERS (2010)
A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?
Matteo Caleo et al.
JOURNAL OF NEUROCHEMISTRY (2009)
A long-term follow-up of botulinum toxin A in cervical dystonia
B. Mohammadi et al.
NEUROLOGICAL RESEARCH (2009)
Do the unintended actions of botulinum toxin at distant sites have clinical implications?
Antonio Curra et al.
NEUROLOGY (2009)
Fifteen-Year Experience in Treating Blepharospasm with Botox or Dysport: Same Toxin, Two Drugs
A. R. Bentivoglio et al.
NEUROTOXICITY RESEARCH (2009)
Discussion of unique properties of botulinum toxins
Alberto Albanese
TOXICON (2009)
Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A
Dorina Tiple et al.
JOURNAL OF NEUROLOGY (2008)
Longitudinal Follow-Up of Adductor Spasmodic Dysphonia Patients After Botulinum Toxin Injection: Quality of Life Results
Randal C. Paniello et al.
LARYNGOSCOPE (2008)
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay
Mitchell F. Brin et al.
MOVEMENT DISORDERS (2008)
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D. M. Simpson et al.
NEUROLOGY (2008)
Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia
Paul K. Holden et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2007)
Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia
I. M. Skogseid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia
Mary Ann Chapman et al.
CLINICAL THERAPEUTICS (2007)
Botulinum toxin in movement disorders
Spiridon Papapetropoulos et al.
SEMINARS IN NEUROLOGY (2007)
Botulinum toxin changes intrafusal feedback in dystonia:: A study with the tonic vibration reflex
Carlo Trompetto et al.
MOVEMENT DISORDERS (2006)
Neurophysiological effects of botulinum toxin type A
G. Abbruzzese et al.
NEUROTOXICITY RESEARCH (2006)
Immunological aspects of Botox®, Dysport® and Myobloc™/NeuroBloc®
D Dressler et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Long-term botulinum toxin efficacy, safety, and immunogenicity
NI Mejia et al.
MOVEMENT DISORDERS (2005)
The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment
IM Skogseid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia
B Berman et al.
MOVEMENT DISORDERS (2005)
Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX (R)) for cervical dystonia
A Brashear et al.
ADVANCES IN THERAPY (2005)
Health-related quality of life in blepharospasm or hemifacial spasm
J Reimer et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Clinical comparability of marketed formulations of botulinum toxin
C Sampaio et al.
MOVEMENT DISORDERS (2004)
Basic immunological aspects of botulinum toxin therapy
MZ Atassi
MOVEMENT DISORDERS (2004)
Treatment of cervical dystonia with botulinum toxin
J Jankovic
MOVEMENT DISORDERS (2004)
Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
P Haussermann et al.
MOVEMENT DISORDERS (2004)
Different types of botulinum toxin in humans
R Eleopra et al.
MOVEMENT DISORDERS (2004)
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004
M Brainin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia
JF Damrose et al.
JOURNAL OF VOICE (2004)
Safety of botulinum toxin type A: a systematic review and meta-analysis
M Naumann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Botulinum toxin in clinical practice
J Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure
D Dressler et al.
JOURNAL OF NEUROLOGY (2003)
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
J Jankovic et al.
NEUROLOGY (2003)
Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis
D Dressler et al.
EUROPEAN NEUROLOGY (2003)
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
GYR Hsiung et al.
MOVEMENT DISORDERS (2002)
The impact of blepharospasm and cervical dystonia on health-related quality of life and depression
J Müller et al.
JOURNAL OF NEUROLOGY (2002)
What are the determinants of quality of life in people with cervical dystonia?
Y Ben-Shlomo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Botulinum toxin A treatment for primary hemifacial spasm - A 10-year multicenter study
G Defazio et al.
ARCHIVES OF NEUROLOGY (2002)
Pathophysiology of dystonia: A neuronal model
JL Vitek
MOVEMENT DISORDERS (2002)
Antibody-induced botulinum toxin therapy failure: Can it be overcome by increased botulinum toxin doses?
D Dressler et al.
EUROPEAN NEUROLOGY (2002)
Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
R Hilker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Tetanus and botulinum neurotoxins: turning bad guys into good by research
O Rossetto et al.
TOXICON (2001)
分享论文
